- Home
- TRT vs ENLV Comparison
TRT vs ENLV Comparison
Compare TRT & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRT
- ENLV
- Stock Information
- Founded
- TRT 1958
- ENLV 2005
- Country
- TRT United States
- ENLV Israel
- Employees
- TRT N/A
- ENLV N/A
- Industry
- TRT Industrial Machinery/Components
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- TRT Technology
- ENLV Health Care
- Exchange
- TRT Nasdaq
- ENLV Nasdaq
- Market Cap
- TRT 22.5M
- ENLV 20.7M
- IPO Year
- TRT N/A
- ENLV 1995
- Fundamental
- Price
- TRT $4.86
- ENLV $1.03
- Analyst Decision
- TRT
- ENLV Strong Buy
- Analyst Count
- TRT 0
- ENLV 2
- Target Price
- TRT N/A
- ENLV $10.00
- AVG Volume (30 Days)
- TRT 5.0K
- ENLV 54.5K
- Earning Date
- TRT 05-13-2025
- ENLV 06-13-2025
- Dividend Yield
- TRT N/A
- ENLV N/A
- EPS Growth
- TRT N/A
- ENLV N/A
- EPS
- TRT 0.00
- ENLV N/A
- Revenue
- TRT $35,548,000.00
- ENLV N/A
- Revenue This Year
- TRT N/A
- ENLV N/A
- Revenue Next Year
- TRT N/A
- ENLV N/A
- P/E Ratio
- TRT $1,112.34
- ENLV N/A
- Revenue Growth
- TRT N/A
- ENLV N/A
- 52 Week Low
- TRT $4.85
- ENLV $0.81
- 52 Week High
- TRT $7.88
- ENLV $1.76
- Technical
- Relative Strength Index (RSI)
- TRT 38.01
- ENLV 53.89
- Support Level
- TRT $5.10
- ENLV $0.97
- Resistance Level
- TRT $5.69
- ENLV $1.09
- Average True Range (ATR)
- TRT 0.21
- ENLV 0.06
- MACD
- TRT 0.02
- ENLV 0.00
- Stochastic Oscillator
- TRT 0.00
- ENLV 45.45
About TRT Trio-Tech International
Trio-Tech International is a provider of third-party semiconductor testing and burn-in services through its laboratories in Southeast Asia. The company operates in four segments namely Manufacturing, Testing services, Distribution, and Real Estate. Its Manufacturing segment manufactures both front-end and back-end semiconductor test equipment and related peripherals. The Testing Services segment renders services to the manufacturer and purchaser of semiconductors and other entities. Its Distribution segment is involved in the distribution of its products. The company's Real Estate segment consists of investment in real estate. Its geographical area of operations includes the United States, Singapore, Malaysia, Thailand, and China. It derives maximum revenue from Testing services Segment.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.